Jeffrey Hung
Genentech · 28 works · 7,772 citations · h-index 12
Top works
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
- Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
- Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1)
- OTULIN limits cell death and inflammation by deubiquitinating LUBAC
- Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
- Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors
- Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation
- The IL-22–oncostatin M axis promotes intestinal inflammation and tumorigenesis
- Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells
- Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain
- The tumor suppressor BAP 1 cooperates with BRAFV 600E to promote tumor formation in cutaneous melanoma
- IL-4-induced SOX9 confers lineage plasticity to aged adult lung stem cells
- Characterization of Tumor-immune Microenvironment by High-throughput Image Analysis of CD8 Immunohistochemistry Combined With Modified Masson’s Trichrome
- Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity
- Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
- Diffusion tensor MRI is sensitive to fibrotic injury in a mouse model of oxalate-induced chronic kidney disease
- Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
- Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity
- A single MHCII neoepitope mRNA vaccine elicits CD4 T- and B- cell responses promoting endogenous CD8 anti-tumor immunity